Andrew C. Rearick International Counsel

Andrew C. Rearick [email protected] International Counsel, London +44 20 7786 9158

Andrew Rearick is a U.S.-qualified (New York and Massachusetts) and English-qualified international counsel in the Corporate Department. His practice covers a full range of cross-border corporate transactional matters for private equity and other institutional investors, as well as corporates, focusing in particular on mergers & acquisitions, joint ventures and other transformative transactions involving businesses centered in Europe, North America and emerging markets. Andrew is also a leader in the firm’s Alternative Asset and Secondary Investments Group, where he regularly advises general partners, secondaries fund sponsors, sovereign wealth funds and other investors on secondary transactions, GP-led restructurings and tender offers, preferred equity investments, co-investments and GP staking transactions. He has advised on transactions across many industries but has particular experience in the financial services, telecommunications, media and technology and energy and natural resources sectors. Mr. Rearick is recommended for private equity transactions by The Legal 500

www.debevoise.com Andrew C. Rearick [email protected] International Counsel, London +44 20 7786 9158

UK (2018). Mr. Rearick’s recent published articles include “Debevoise Discusses Private Equity Options in Face of Liquidity Crunch,” The CLS Blue Sky Blog (May, 2020); “The market for GP-led fund restructurings is maturing,” Private Funds CFO (June, 2019); “Three’s Company: An Evolving Market in Private Equity Add-On Transactions,” The M&A Lawyer (November/December, 2014); “Fifty Shades of Co-Investing: Part Two,” Private Equity Manager (February, 2013) and “Fifty Shades of Co-Investing: Part One,” Private Equity Manager (January, 2013). Mr. Rearick joined Debevoise in 2007. He graduated in 1999 with an A.B. cum laude from Princeton University. He received his J.D. in 2007 from the University of California, Berkeley (Boalt Hall School of Law), where he was an articles editor of the Berkeley Journal of International Law. Mr. Rearick is fluent in Russian and French and previously lived and worked in the former Soviet Union, France and the Netherlands.

www.debevoise.com Andrew C. Rearick [email protected] International Counsel, London +44 20 7786 9158

ANDREW C. REARICK'S SELECT REPRESENTATIONS

Pantheon and LGT Capital Glendower Capital in its role Helios Investment Partners Modex in its acquisition of Partners as lead investors in a as part of a consortium of and its investment vehicle Gauthier Homes and continuation vehicle blue-chip institutional Samba Luxco in the Gauthiers’ Oilfield Rental. sponsored by Medicxi, a investors to invest settlement of claims made in Clayton, Dubilier & Rice in the European life sciences approximately $530 million in an ICC Arbitration regarding financing aspects of its investor, involving six six companies controlled by Samba's stake in Africatel. €1.2 billion acquisition of preclinical- and clinical-stage Argonne Capital Group. The settlement involved Mauser Group, one of the assets. reducing Samba’s stake in Tristan Capital in its sale of a world’s leading industrial Africatel from 25% to 14%, Exponent in a £125 million 40% interest in Tristan to packaging companies. and the transfer from preferred equity facility for Candriam, a New York Life Africatel to Samba of a 34% Helios Investment Partners Exponent Private Equity affiliate. stake in Mobile in its acquisition of a majority Partners III, a £1 billion buyout Clayton, Dubilier & Rice in its Telecommunications, the stake in Telkom Kenya from fund. acquisition of a 40% Namibian telecoms operator. The Orange Group. Link Fund Solutions as ownership interest in Belron, AltaOne Capital in its Stone Point Capital in its sale authorised corporate director which valued the company at acquisition, with Silver Lake, of Genex, a provider of of the LF Equity Income Fund €3 billion. of a 37.6% interest in Cegid healthcare and disability in the £224 million sale of A secondaries investor as the Group, valuing the company management services, to shares in 19 public and private lead investor in the at ?€580 million. Apax Partners. life sciences companies to recapitalization of two “end- Acacia Research Corporation HarbourVest Partners in its Schneider Electric in the sale of-life” funds, sponsored by by the LF Equity Income Fund. co-investment with IK of its custom sensors and the same manager, in a Investment Partners in the technologies division to HarbourVest Partners and merger transaction designed Salad Signature group, a Carlyle and PAI, based on an Pantheon as investors in 3i’s to offer liquidity to existing Dutch and Belgian food enterprise value of GP-led single asset fund investors. business. $900 million, and its restructuring, one of the Caisse de dépôt et reinvestment of largest-ever such Eutelsat in a joint venture placement du Québec in its approximately $100 million. transactions which involved with ViaSat to provide investment in Datamars. moving Action, with a post- wholesale and retail StoneRiver Group in the discount enterprise value of B&M in its £250 million bond broadband services in Europe. formation of a joint venture €10.25 billion, to a offering of 4.125% senior with funds managed by Kelso American Securities and P2 continuation vehicle. secured notes due 2022, and & Company in which Capital Partners in their its related refinancing of StoneRiver Group’s A consortium of international $855 million acquisition of certain of its existing senior Progressive Medical was secondaries fund sponsors Blount International. credit facilities. merged with PMSI. The led by Pantheon and Stone Point Capital as an combined company will Aberdeen Standard in a fund Deutsche Bank in its co- anchor investor in the deliver comprehensive recapitalization involving the investment into Medi-Globe. formation of Cross Ocean workers’ compensation single-asset transfer of KD Partners, including the pharmacy benefit Pharma Group, a German Johnson & Johnson in its acquisition of a significant management services vitamin supplement acquisition from AstraZeneca stake in the management including end-to-end manufacturer, and related of the global rights outside of company and GP, and the pharmacy, ancillary and investment transaction. the U.S. to Rhinocort Aqua, a line of nasal sprays used to acquisition by Cross Ocean settlement solutions. Clayton, Dubilier & Rice and treat allergies. Partners of the European Debevoise advised BrandSafway in the Special Situations business StoneRiver in its capacity as $6.2 billion sale of Clayton, Dubilier & Rice in the from Capula Investment sellers of a controlling BrandSafway to Brookfield financing and certain other Management. interest in Progressive and Business Partners L.P. and aspects of its acquisition of also represented StoneRiver Eutelsat in a partnership CD&R Fund X. BUT, the largest furniture in the governance initiative to provide data retailer network in France, in a arrangements with respect to DH Private Equity in its sale connectivity to Sub-Saharan 50:50 partnership with WM post-closing operations of of the two remaining assets in Africa. Holding, a company related to the combined company. fund DH IV to fund DH IV.1, a the XXXLutz Group. HarbourVest Partners in the new fund also managed by DH Cinram, a portfolio company €400 million secondary Private Equity. of Najafi Companies, in its acquisition, through a newly- acquisition of Saffron Digital formed fund managed by Media from HTC. Portobello Capital, of the private equity portfolio of Portobello Capital II LP, as part of a fund restructuring.

www.debevoise.com Andrew C. Rearick [email protected] International Counsel, London +44 20 7786 9158

One of Deutsche Bank’s SPIE in its €375 million Stone Point Capital in its Central European Media private equity platforms in its offering of 11% senior notes investment in Lockton Enterprises in a joint venture acquisition of interests in due 2019. International Holdings. with Ukrainian businessman Calastone, Graze, Secret Igor Kolomoisky, a CME Exal Corporation, a Teachers Stone Point Capital in its sale Escapes and Zoopla Property director and shareholder, to Private Capital portfolio of an interest in Securis Group from Octopus, a unite operations of CME's company, in the €85 million Investment Partners, an leading specialist fund Ukrainian television group sale of its European division insurance-linked securities management company. "Studio 1+1" with to Ardagh Group. manager. Kolomoisky's TET TV channel. Clayton, Dubilier & Rice in its Exova in its £155 million high- Clayton, Dubilier & Rice, AXA acquisition of a significant Cunningham Lindsey in its yield offering of 10.5% senior Private Equity and Caisse de stake in B&M Retail. recapitalization by CVC notes. dépôt et placement du Capital Partners. Baring Vostok Capital Québec in the €2.1 billion HarbourVest Partners in its Partners, as selling acquisition of SPIE from PAI investment in BenefitMall and shareholder in the $1.4 billion Partners. CompuPay. Nasdaq initial public offering Central European Media by Yandex, the leading Clayton, Dubilier & Rice in its Enterprises in its sale of the internet company and most acquisition of British Car Studio 1+1 and Kino television popular search engine in Auctions. channels to Igor Kolomoisky. Russia.